Results of induction therapy in adults younger than 60 years with AML, by cytogenetics
| Reference . | Favorable CR . | Intermediate CR . | Unfavorable . | |
|---|---|---|---|---|
| N . | CR . | |||
| MRC (1998)8 | 90 | 84 | 130 | 57% |
| ECOG/SWOG (1998)38 | 84 | 76 | 184 | 55% |
| GOELAMS (1997)90 | 87 | 76 | 36 | 58% |
| Reference . | Favorable CR . | Intermediate CR . | Unfavorable . | |
|---|---|---|---|---|
| N . | CR . | |||
| MRC (1998)8 | 90 | 84 | 130 | 57% |
| ECOG/SWOG (1998)38 | 84 | 76 | 184 | 55% |
| GOELAMS (1997)90 | 87 | 76 | 36 | 58% |
Adapted from Appelbaum et al.91